InsiderTrades.com logo

CRTX Insider Trading

Insider Ownership Percentage: 97.32%
Insider Buying (Last 12 Months): £199,398.16
Insider Selling (Last 12 Months): GBX 0

CRISM Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at CRISM Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

CRISM Therapeutics Share Price & Price History

Current Price: GBX 11.70
Price Change: ▼ Price Decrease of -0.3 (-2.50%)
As of 12/4/2025 12:43 PM ET

This chart shows the closing price history over time for CRTX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

CRISM Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/7/2025Gerald BeaneyInsiderBuy20,182GBX 988£199,398.16
See Full Table

SEC Filings (Institutional Ownership Changes) for CRISM Therapeutics (LON:CRTX)

0.28% of CRISM Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

CRISM Therapeutics Corporation is clinical stage company, having developed an innovative drug delivery technology to improve the clinical performance of cancer treatments for solid tumours through the local delivery of chemotherapy drugs. ChemoSeed, CRISM’s lead product, can be implanted directly into the tumour or the resection margin following the removal of a tumour. This directs that therapeutic concentrations of chemotherapy drugs reach the deep-seated tumour tissue or cover the entire resection margin. In the case of treating glioblastoma, ChemoSeeds can be implanted during surgery thereby bypassing the blood brain barrier, which prevents other treatments from being able to reach the tumour and be effective. CRISM will initiate its registration-grade Phase 2 clinical trial of irinotecan-ChemoSeed in patients with surgically resectable glioblastoma in Q1 2026. For more information please visit: https://www.crismtherapeutics.com
Read More on CRISM Therapeutics

Today's Range

Now: GBX 11.70
Low: 10
High: 13

50 Day Range

MA: GBX 11.14
Low: 8.45
High: 13.15

52 Week Range

Now: GBX 11.70
Low: 5.64
High: 29.40

Volume

24,475 shs

Average Volume

69,582 shs

Market Capitalization

£4.68 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.81

Who are the company insiders with the largest holdings of CRISM Therapeutics?

CRISM Therapeutics' top insider investors include:
  1. Gerald Beaney (Insider)
Learn More about top insider investors at CRISM Therapeutics.